Ecopetrol Targets USD 13 Billion-14 Billion in Annual EBITDA by 2040
Bitget2026/10/22 21:17- Ecopetrol targets annual EBITDA of USD 13 billion-14 billion by 2040, with hydrocarbons and diversification each contributing half.
- Capital allocation is targeted at 60% hydrocarbons and 40% low-emissions businesses by that year.
- ISA's contribution is expected to reach 22%-26% of group EBITDA over the same horizon.
- The FEPC balance is forecast at COP 8 trillion-12 trillion at year-end 2026, depending on Brent prices and exchange rates.
- The first-half FEPC balance stood at COP 8 trillion, including COP 6 trillion accrued during the period.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
